Corona Remedies Legal & Regulatory

Corona Remedies Earnings Call Transcript: Key Takeaways

CORONA delivered robust revenue growth of 22% YoY, outperforming the Indian pharmaceutical market by focusing on chronic segments. Management maintains a growth target of 1.5x the market rate.

Call

Guides 15% growth

Corona Remedies Investor Presentation: Key Takeaways

Q2FY27 revenue ₹441.2Cr (+22.2%), PAT ₹60.3Cr (+15.3%); H1 revenue ₹863.6Cr (+22.0%), PAT ₹120.4Cr (+22.2%). Chronic-led growth, outpacing IPM.

Corona Remedies Results Update

Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.

Corona Remedies Q2 FY27 Results: Net Profit ₹60.3 Cr, Up 15.3% YoY

Corona Remedies Ltd reported revenue from operations of ₹441.2 Cr (+22.2% YoY) and net profit of ₹60.3 Cr (+15.3% YoY) for Q2 FY27.

Key figure

Net profit ₹60.3 Cr · +15.3% YoY

Corona Remedies Business Update

Corona Remedies received GMP Compliance Certification from Brazil's ANVISA for its OSD and Hormone facilities in Ahmedabad. This validates export eligibility to the Brazilian pharmaceutical market.

Corona Remedies Board Meeting Date

Corona Remedies Limited will hold a board meeting on October 30, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.

Easy Trip Planners Legal & Regulatory

Easy Trip Planners received a GST show-cause notice proposing a penalty of about Rs 67.41 Crore. The company expects no immediate financial impact and will contest it.

Value

₹67.41 Cr

Ruparel Food Products Legal & Regulatory

Ruparel Food Products paid a Rs 2,360 BSE fine for a late Regulation 34 annual report. The company says Regulation 43A does not apply to it.

Value

₹0.00 Cr

Integra Switchgear Legal & Regulatory

Integra Switchgear received a SEBI adjudication order levying penalties of ₹13 lakh. The erstwhile promoters have undertaken to bear any resulting liability.

Value

₹0.13 Cr

From

Securities and Exchange Board of India (SEBI)

Airfloa Rail Technology Legal & Regulatory

Airfloa Rail received a Madras High Court interim stay on CSR penalties under Section 135(7). Conditional relief requires paying 50% of the ROC penalty within twelve weeks.

Value

₹1.05 Cr

Timken India Legal & Regulatory

Timken India's GST appeal was rejected, upholding a Rs 8.19 Crore demand plus interest and penalty. The company plans to appeal and expects no immediate financial impact.

Value

₹8.19 Cr

Allied Blenders & Distillers Legal & Regulatory

Allied Blenders disclosed that the Bombay High Court appointed a Sole Arbitrator to adjudicate a dispute with former employee Mr. Alok Gupta over his employment agreement. No financial implication or quantum of claims is ascertainable at present.